𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Corticosteroid iontophoresis to treat carpal tunnel syndrome: A double-blind randomized controlled trial

✍ Scribed by Nasim Amirjani; Nigel L. Ashworth; M. Joe Watt; Tessa Gordon; K. Ming Chan

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
230 KB
Volume
39
Category
Article
ISSN
0148-639X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double blind randomized placebo contro
A double blind randomized placebo control trial of levetiracetam in tourette syndrome
✍ Constance L. Smith-Hicks; Dana D. Bridges; Nina P. Paynter; Harvey S. Singer 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 1 views

## Abstract The objective of this study was to investigate the effectiveness of levetiracetam for the treatment of tics in children with Tourette syndrome (TS). Levetiracetam, an atypical anticonvulsant, has been suggested in open‐label protocols to be an effective tic‐suppressing agent in individu

Treating alcohol withdrawal with oral ba
Treating alcohol withdrawal with oral baclofen: A randomized, double-blind, placebo-controlled trial
✍ Jeffrey E. Lyon; Raza A. Khan; Charles E. Gessert; Pamela M. Larson; Colleen M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB

## Abstract ## BACKGROUND: Abrupt cessation of alcohol intake causes habituated drinkers to experience symptoms of alcohol withdrawal syndrome (AWS). ## OBJECTIVE: To determine the effect of the gamma‐aminobutyric acid (GABA)‐B agonist baclofen on the course of acute symptomatic AWS. ## DESIGN:

Etanercept in Sjögren's syndrome: A twel
Etanercept in Sjögren's syndrome: A twelve-week randomized, double-blind, placebo-controlled pilot clinical trial
✍ Vidya Sankar; Michael T. Brennan; Marc R. Kok; Rose Anne Leakan; Janine A. Smith 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 1 views

## Abstract ## Objective To assess the safety and potential efficacy of etanercept in the treatment of Sjögren's syndrome (SS). ## Methods This pilot study was a 12‐week randomized, double‐blind, placebo‐controlled trial of etanercept, with 14 subjects in each group. Patients received 25 mg of e